De Giorgis, V., Bhatia, K. P., Boespflug‐Tanguy, O., Gras, D., Marina, A. D., Desurkar, A., Toledo, M., Miller, I., Rotstein, M., Schneider, S. A., Tarquinio, D. C., Weber, Y., Brandabur, M., Mayhew, J., Koutsoukos, T., & De Vivo, D. C. (2024). Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study. Movement Disorders, 39(8), 1386–1396. Portico. https://doi.org/10.1002/mds.29822